Related Experiment Video
Updated: Aug 29, 2026

Mouse Models for Graft Arteriosclerosis
Published on: May 14, 2013
Interferon regulatory factor-1 mediates PPARgamma-induced apoptosis in vascular smooth muscle cells
Yiming Lin1, Xiaojun Zhu, Farron L McLntee
1Cardiovascular Research Institute, Morehouse School of Medicine, 720 Westview Drive SW, Atlanta, GA 30310, USA.
Objective:
Peroxisome proliferator-activated receptor gamma (PPARgamma) possesses general beneficial effects on the cardiovascular system, such as inhibition of vascular lesion formation and atherosclerosis. However, molecular mechanisms for these effects are yet to be fully defined. The aim of this study is to elucidate whether interferon regulatory factor-1 (IRF-1), a transcriptional factor with anti-proliferative and pro-apoptotic properties, mediates PPARgamma-induced apoptosis in vascular smooth muscle cells (VSMCs).
Methods And Results:
Using Northern and Western blot analyses, we documented that PPARgamma ligands, including ciglitazone, troglitazone, and GW7845, significantly increased IRF-1 expression in VSMCs; however, the PPARalpha ligand (Wy14643) and PPARdelta ligand (GW0742) did not affect its expression. PPARgamma-induced IRF-1 expression was abrogated by pretreatment with the PPARgamma antagonist GW9662. In contrast, adenoviral expression of PPARgamma in VSMCs dramatically increased IRF-1 level. Furthermore, PPARgamma activation increased IRF-1 promoter activity but did not affect IRF-1 mRNA stability. Finally, reducing IRF-1 expression by antisense technology attenuated PPARgamma-induced VSMC apoptosis through decreasing cyclin-dependent kinase inhibitor p21(cip1) and caspase-3 activity.
Conclusions:
Our data demonstrate that IRF-1 is a novel PPARgamma target gene and mediates PPARgamma-induced VSMC apoptosis.
Insights
Interferon regulatory factor-1 (IRF-1) mediates beneficial cardiovascular effects of peroxisome proliferator-activated receptor gamma (PPARgamma) by inducing apoptosis in vascular smooth muscle cells (VSMCs). This study identifies IRF-1 as a novel PPARgamma target gene.
Area of Science:
- Cardiovascular Biology
- Molecular Biology
- Cell Biology
Background:
- Peroxisome proliferator-activated receptor gamma (PPARgamma) has known cardiovascular benefits, including inhibiting vascular lesion formation and atherosclerosis.
- The precise molecular mechanisms underlying PPARgamma's cardioprotective effects remain incompletely understood.
Purpose of the Study:
- To investigate whether interferon regulatory factor-1 (IRF-1), a transcription factor with anti-proliferative and pro-apoptotic properties, mediates PPARgamma-induced apoptosis in vascular smooth muscle cells (VSMCs).
Main Methods:
- Utilized Northern and Western blot analyses to assess IRF-1 expression in VSMCs.
- Employed PPARgamma ligands and antagonists (ciglitazone, troglitazone, GW7845, GW9662) to study gene regulation.
- Investigated IRF-1 promoter activity and mRNA stability.
- Used adenoviral expression and antisense technology to manipulate IRF-1 levels.
Main Results:
- PPARgamma ligands significantly increased IRF-1 expression in VSMCs, an effect blocked by the PPARgamma antagonist GW9662.
- PPARgamma activation enhanced IRF-1 promoter activity but did not alter mRNA stability.
- Reduced IRF-1 expression attenuated PPARgamma-induced VSMC apoptosis, decreasing p21(cip1) and caspase-3 activity.
Conclusions:
- Interferon regulatory factor-1 (IRF-1) is identified as a novel target gene of PPARgamma.
- IRF-1 mediates the pro-apoptotic effects of PPARgamma in vascular smooth muscle cells, contributing to its cardiovascular benefits.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
The Extrinsic Apoptotic Pathway
TGF - β Signaling Pathway
The Intrinsic Apoptotic Pathway
Inhibitors of Viral Protein Synthesis
Regulation of the Unfolded Protein Response
